Skip to main content

DOI: 10.1128/mbio.02070-23

Submitted by JessicaWheeler on
NPRC/Institute
UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA; University of Pittsburgh School of Medicine , Pittsburgh, Pennsylvania, USA; others
Summary of Study
Tetravalent SARS-CoV-2 S1 subunit protein vaccination
Year Published
2023
References
DOI: 10.1128/mbio.02070-23
Contact Info
Andrea Gambotto: gambottoa@upmc.edu
Keywords
SARS-CoV-2, tetravalent vaccine, adjuvant, immune response, primates
Coronavirus Investigated*
NHP Species
date entered
Study Type